Indo US Organization for Rare Diseases

Our mission highlights patient-centric programs that align with the FDA's patient-focused drug development (PFDD) paradigm. These initiatives include the Diversity Patients Alliance Program, a tech-enabled Patients Concierge, the Corporate Diversity Advisory Council (CDAC), research programs, and national and international conferences, all aimed at providing substantial support and engagement for those affected.